Januvia® / Janumet®

Januvia® and Janumet®Cancer Risks Experienced Legal Representation

More than 35 Years of Experience―The Law Office of Rudolph F. X. Migliore, P.C.

Have you been prescribed Januvia® or Janumet® for treatment of diabetes mellitus type 2? Have you suffered severe pancreatitis or sad-mandeveloped pancreatic or thyroid cancer? There may be a link between your use of the medication and your illness. Let us help you protect your legal rights.

Protect your Legal Rights

At the law office of Rudolph F. X. Migliore, P.C., in Commack, we bring three decades of legal experience to injured people across Long Island, Suffolk County and Nassau County. We strive to provide first-class professional service at all times, listening carefully to your concerns, and aggressively protecting your interests throughout the legal process. We have served and are currently working as co-counsel with other experienced attorneys to investigate and prosecute medical product liability claims, including cases involving injuries tied to the use of Januvia® and Janumet®.

Contact our office online or call us at 1-888-980-RFXM for a free initial consultation.

What is Januvia®/Janumet®?

Januvia® is the trade name for sitagliptin, an oral medication prescribed to adults with diabetes mellitus type 2. It was developed, and is currently marketed in the United States by Merck & Co. Janumet® is a combination pill that also contains metformin, a diabetes medication that suppresses glucose production by the liver.

Who is potentially liable for your injuries?

In cases involving dangerous or defective products, including prescription drugs, you may generally seek damages against anyone in the “chain of distribution,” including the manufacturer, any testing lab or facility, the doctor or physician who prescribed it, a pharmaceutical sales representative, or a hospital, clinic or pharmacy that dispensed it.

What side effects or health concerns have been linked to Januvia®/Janumet®?

In 2009, the U.S. Food and Drug Administration (FDA) mandated a revision to the warning label on both Januvia® and Janumet®, requiring that it inform users of the potential risks of pancreatic cancer and thyroid cancer. The drug had already been linked to cases of severe pancreatitis. A study reported in the Journal of the American Medical Association (JAMA), in February, 2013, found that people using Januvia had twice the rate of acute pancreatitis as those who did not. Another recent study showed increases in pancreatic and beta cell mass in Januvia users. These factors are symptomatic of pancreatic cancer.

How can our law office help you?

Our firm will conduct a thorough investigation of the facts and circumstances of your case, working with co-counsel to gather, evaluate and preserve all evidence in your case. We will help you seek compensation for all your losses, including wages and income, unreimbursed medical expenses, physical pain or suffering, and loss of companionship or consortium. You will always have direct access to one of our attorneys, so that you get timely and accurate answers to your questions.

Our law firm handle all types of cancer claims for people who have used Januvia® or Janumet®, as well as actions seeking damages for severe pancreatitis.

Contact the Law Office of Rudolph F. X. Migliore, P.C.

Our firm offers a free initial consultation to anyone with health concerns related to their use of the prescription drugs Januvia® or Janumet®. We will carefully evaluate the facts of your case to determine whether you have grounds to file a lawsuit, and will oversee your claim through to settlement or verdict. Any fees you owe us for legal representation will be paid out of your final settlement.

To schedule an appointment, e-mail or call our office toll free at 1-888-980-RFXM.

Contact Our Firm